Objective: To determine the risk of persistent renal insufficiency (RI) in premature infants following the use of antenatal indomethacin for suppression of preterm labor.

Study Design: This population-based, retrospective review consisted of infants admitted during a 5-year period (1994-1999) to a tertiary referral neonatal intensive care nursery. Data were reviewed on 37 infants whose mothers received indomethacin for tocolysis, and on 37 matched controls. Renal insufficiency was defined as infant creatinine (Cr) > or = 1.5 mg/dl (133 micromol/l) for > or = 1 day.

Results: Infants whose mothers had received indomethacin for tocolysis were more likely than matched controls to have RI (9 of 37 vs 2 of 37, p = 0.04). Among infants of indomethacin-treated mothers with elevated Cr, serum Cr remained > or = 1.5 mg/dl (133 micromol/l) for a median of 6 days and > 1.0 mg/dl (88 micromol/l) for a median of 19 days. The peak Cr and length of elevation were closely correlated (r(2) = 0.63, p < 0.0001).

Conclusion: Antenatal indomethacin can result in significant, prolonged RI in the infant. It may pose important risks to renal function and homeostasis in premature infants.

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.jp.7210790DOI Listing

Publication Analysis

Top Keywords

renal insufficiency
12
premature infants
12
risk persistent
8
persistent renal
8
insufficiency premature
8
indomethacin suppression
8
suppression preterm
8
antenatal indomethacin
8
infants mothers
8
mothers received
8

Similar Publications

Background: This case report describes a unique presentation of sphingosine-1-phosphate lyase insufficiency syndrome (SPLIS) caused by a rare SGPL1 variant, highlighting the diagnostic and management challenges associated with this condition.

Case Presentation: A 2-year-old Iranian female presented with steroid-resistant nephrotic syndrome (NS), primary adrenal insufficiency (AI), growth delay, seizures, and hyperpigmentation. Laboratory evaluation revealed hypoalbuminemia, significant proteinuria, hyperkalemia, and elevated adrenocorticotropic hormone (ACTH) levels.

View Article and Find Full Text PDF

Risk of severe maternal morbidity and mortality among pregnant patients with chronic kidney disease: Renal disease and severe maternal morbidity.

Am J Obstet Gynecol MFM

January 2025

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, Ohio 45267, USA. Electronic address:

Background: Chronic kidney disease is a significant cause of adverse obstetric outcomes. However, there are few studies assessing the risk of severe maternal morbidity and mortality among patients with chronic kidney disease and no studies assessing the association between individual indicators of severe maternal morbidity and chronic kidney disease.

Objective: To evaluate the risk of severe maternal morbidity and mortality among pregnant patients with chronic kidney disease.

View Article and Find Full Text PDF

Background: Acute kidney injury (AKI) is a common complication in hospitalized older patients, associated with increased morbidity, mortality, and health care costs. Major adverse kidney events within 30 days (MAKE30), a composite of death, new renal replacement therapy, or persistent renal dysfunction, has been recommended as a patient-centered endpoint for clinical trials involving AKI.

Objective: This study aimed to develop and validate a machine learning-based model to predict MAKE30 in hospitalized older patients with AKI.

View Article and Find Full Text PDF
Article Synopsis
  • Acute kidney injury (AKI) affects a significant number of critically ill patients, with the lack of standardized tools for implementing KDIGO criteria creating challenges for researchers.
  • The pyAKI pipeline was developed to address these issues, using the MIMIC-IV database to establish a standardized model for consistent AKI diagnosis.
  • Validation tests showed that pyAKI performs better than human annotations, achieving perfect accuracy and offering a valuable resource for clinicians and data scientists in AKI research.
View Article and Find Full Text PDF

Relationship between oxidative balance indicators and Chronic Kidney Disease.

PLoS One

January 2025

Department of Nephrology, Institute of Kidney Diseases, West China Hospital, Sichuan University, Chengdu, China.

Article Synopsis
  • Chronic Kidney Disease (CKD) affects about 9.1% of the global population, with oxidative stress linked to its development through indicators like Oxidative Balance Score (OBS) and Pro-Oxidant-Antioxidant Balance (PAB).
  • This study analyzed data from 18,951 participants in the NHANES survey to explore the connections between these oxidative indicators and CKD risk using advanced statistical methods.
  • Results showed higher OBS and PAB levels correlated with a reduced risk of CKD, with OBS proving to have the most predictive ability, while Total Antioxidant Capacity (TAC) did not show a significant association.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!